Loading ARQT charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading ARQT comparable companies…
| ARQTArcutis Biotherapeutics, Inc.(opens in a new tab) | $4.36B | $0.46B | +76.1% | 91.1% | 7.4% | 9.39× | 152.6× |
|---|---|---|---|---|---|---|---|
| CRMDCorMedix Inc.(opens in a new tab) | $0.53B | $0.46B | +280.5% | 82.8% | 47.0% | 1.14× | 2.8× |
| ORGOOrganogenesis Holdings Inc.(opens in a new tab) | $0.10B | $0.46B | +6.5% | 75.9% | −7.8% | 0.22× | — |
| LQDALiquidia Corp(opens in a new tab) | $4.56B | $0.45B | +2233.6% | 58.1% | 37.4% | 10.12× | 32.4× |
| ARDXArdelyx, Inc.(opens in a new tab) | $0.75B | $0.45B | +16.8% | 94.4% | −7.9% | 1.66× | — |
| Medianpeers, excl. ARQT | $0.64B | $0.45B | +148.6% | 79.3% | 14.8% | 1.40× | 17.6× |